Kochi: Fujifilm India, a global leader in healthcare technology, introduced its latest innovation in lung navigation, Synapse 3D, during the ABIP (Amrita Bronchoscopy and Interventional Pulmonology) event held in Kochi on Sunday.
Synapse 3D represents a groundbreaking advancement in pulmonary imaging and diagnostics. Leveraging state-of-the-art 3D technology, this device offers unparalleled precision and insight into pulmonary conditions, empowering healthcare professionals with the tools they need to deliver optimal patient care.
Synapse 3D uses specialized technology to identify three optimal lung lesion paths, aiding in precise diagnosis and timely intervention. It also performs bronchoscope simulations, saving time and reducing patient discomfort, resulting in a better diagnosis.
Fujifilm India’s Head of Endoscopy Systems Division, Dheeraj Chaudhri, while unveiling the Synapse 3D, said it is an innovative device that marks a significant milestone in their journey towards enhancing pulmonary diagnostics and advancing healthcare solutions.
The Amrita Bronchoscopy & Interventional Pulmonology (ABIP) event served as a prominent platform for industry leaders, healthcare professionals, and innovators to convene and exchange insights on the latest advancements in pulmonary care.
With a focus on interventional techniques and emerging technologies, the event facilitated discussions, workshops, and live demonstrations, providing attendees with valuable opportunities to enhance their knowledge and expertise in the field.
Fujifilm India’s Synapse 3D Lung Navigation technology, which provides high-resolution imaging, intuitive navigation, and complete analysis capabilities, is transforming pulmonary diagnostics and tailored patient care, showcasing Fujifilm’s dedication to innovation.
